Reports Q2 revenue $325.84M, consensus $320.69M. Reports 10M HSAs, an increase of 6% compared to Q2 FY25 “The HealthEquity (HQY) team delivered continued momentum during our second quarter with strong 9% revenue growth, record gross margin of 71% and record adjusted EBITDA of $151 million,” said Scott Cutler, president and CEO of HealthEquity. “We believe our outlook is even brighter with our national lawmakers providing the largest legislative expansion of HSAs since 2006 as more American families seek access to the financial security and tax benefits that they provide. Through our proprietary technologies and platforms, Team Purple continues to empower a growing number of savvy healthcare consumers with tools and resources that drive better member outcomes.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HQY:
- Options Volatility and Implied Earnings Moves Today, September 02, 2025
- Options Volatility and Implied Earnings Moves This Week, September 02 – September 04, 2025
- HQY Upcoming Earnings Report: What to Expect?
- HealthEquity’s Strong Financial Outlook and Strategic Shift Drive Buy Rating with $125 Price Target
- HealthEquity price target lowered to $109 from $117 at RBC Capital